FUSITAB Trademark

Trademark Overview


On Monday, October 16, 2000, a trademark application was filed for FUSITAB with the United States Patent and Trademark Office. The USPTO has given the FUSITAB trademark a serial number of 78030862. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Sunday, March 7, 2010. This trademark is owned by Oxford BioMedica plc. The FUSITAB trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems

instruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, namely, syringes, scalpels, catheters, and tubes for the administration of gene therapy products

Scientific and medical research and product development; medical services; genetic engineering services; biotechnology services, namely, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy

General Information


Serial Number78030862
Word MarkFUSITAB
Filing DateMonday, October 16, 2000
Status710 - CANCELLED - SECTION 8
Status DateSunday, March 7, 2010
Registration Number2747063
Registration DateTuesday, August 5, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2002

Trademark Statements


Goods and ServicesGene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems
Goods and Servicesinstruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, namely, syringes, scalpels, catheters, and tubes for the administration of gene therapy products
Goods and ServicesScientific and medical research and product development; medical services; genetic engineering services; biotechnology services, namely, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, March 7, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, March 7, 2010
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, March 7, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford BioMedica plc
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica plc
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica plc
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Trademark Events


Event DateEvent Description
Sunday, March 7, 2010CANCELLED SEC. 8 (6-YR)
Tuesday, June 10, 2008CASE FILE IN TICRS
Tuesday, August 5, 2003REGISTERED-PRINCIPAL REGISTER
Monday, June 9, 2003Sec. 1(B) CLAIM DELETED
Monday, March 24, 2003NOTICE OF ALLOWANCE CANCELLED
Monday, November 25, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 4, 2002PAPER RECEIVED
Friday, October 4, 2002PAPER RECEIVED
Tuesday, September 24, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2002NOTICE OF PUBLICATION
Saturday, March 9, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 4, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 7, 2001LETTER OF SUSPENSION MAILED
Wednesday, November 7, 2001ASSIGNED TO EXAMINER
Monday, October 1, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 1, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 29, 2001NON-FINAL ACTION MAILED
Thursday, March 22, 2001ASSIGNED TO EXAMINER